Infectious Disease Physicians Urge Bayer to Cease Marketing Baytril


ALEXANDRIA, Va. -- The Infectious Diseases Society of America (IDSA) has joined other groups in calling for Bayer Corporation to remove from the market its drug, Baytril, a ciprofloxacin-like antibiotic used in poultry. Infectious disease experts, like consumer groups, are concerned that use of the drug in agriculture may promote antibiotic resistance, making similar drugs less effective in treating bacterial diarrhea in humans.

The Food and Drug Administration (FDA) proposed banning Baytril and other fluoroquinolones in poultry in October 2000. Abbott Laboratories, one of two U.S. manufacturers of these drugs, voluntarily complied with FDA's request, but Bayer appealed the FDA decision. Since then, FDA's review of the scientific evidence has shown that use of Baytril in poultry reduces the effectiveness of ciprofloxacin (Cipro) in treating Campylobacter, a common cause of food-borne illness. Earlier this month, an administrative law judge upheld FDA's proposed ban, but Bayer again appealed the decision to FDA.

IDSA has supported the reasonable and measured approach that FDA has used to address the complex issues involved in evaluating the scientific data. "Now, the evidence has been weighed, a decision reached, and the decision has been upheld by the administrative law judge. It is not reasonable or responsible for Bayer Corporation to continue to resist the decision, and particularly to continue to market their product during the appeals process," said Joseph R. Dalovisio, MD, president of IDSA.

"Bayer's action departs from the precedent of collaboration shown by FDA, the infectious disease community and the other pharmaceutical sponsor. IDSA has strong concerns about Bayer's action, and we ask that they immediately cease marketing of Baytril," he said.

The IDSA, based in Alexandria, Va., is a professional society representing 7,500 physicians and scientists who specialize in infectious diseases.

Source: IDSA

Related Videos
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Association for Professionals in Infection Control and Epidemiology  (Image credit: APIC)
Lila Price, CRCST, CER, CHL, the interim manager for HealthTrust Workforce Solutions; and Dannie O. Smith III, BSc, CSPDT, CRCST, CHL, CIS, CER, founder of Surgicaltrey, LLC, and a central processing educator for Valley Health System
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Related Content